<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02894112</url>
  </required_header>
  <id_info>
    <org_study_id>1198</org_study_id>
    <nct_id>NCT02894112</nct_id>
  </id_info>
  <brief_title>Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal</brief_title>
  <official_title>Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dairy Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas at Austin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidemiological studies indicate that risk of type 2 diabetes is lower when milk is consumed&#xD;
      in the regular diet. Milk products are unique in that they produce high insulin response&#xD;
      despite their low glycemic index. The general aim of the proposed study is to determine the&#xD;
      effect of fluid milk on attenuating the postprandial surge in plasma glucose and triglyceride&#xD;
      after meals and its associated physiological mechanisms. The investigators hypothesize that&#xD;
      the consumption of one or two servings of non-fat milk added to a standard oral glucose&#xD;
      tolerance test (OGTT) solution or the high fat tolerance test meal will attenuate&#xD;
      postprandial hyperglycemia and triglyceridemia. The investigators hypothesize that the&#xD;
      postulated improvement in postprandial metabolic response due to the consumption of fluid&#xD;
      milk will be associated with increased postprandial insulin secretion as well as&#xD;
      insulin-mediated endothelial vasodilation and whole-limb perfusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A double blind randomized placebo-controlled crossover experimental design with six&#xD;
      treatments will be used. A total of 30 young (20-40 year old) healthy men and women will&#xD;
      serve as subjects. Following 2 days of physical activity and dietary control, subjects will&#xD;
      consume a standard OGTT load or high fat tolerance load on the morning of Day 3. The solution&#xD;
      used in the meals will be mixed with one or two servings of non-fat milk or placebo (either&#xD;
      carbohydrate matched or total calorie matched). Before and after the test meals are consumed,&#xD;
      blood samples will be obtained for later analysis of glucose, triglycerides, insulin, and&#xD;
      inflammatory cytokines and brachial artery flow-mediated dilation and femoral artery vascular&#xD;
      conductance will be measured. The present research project should provide new and clinically&#xD;
      useful insight into the role of conventional dairy products on metabolic homeostasis. If the&#xD;
      working hypotheses are supported, the information could be used as an initial/preliminary&#xD;
      basis for recommendations for the consumption of fluid milk in the prevention of metabolic&#xD;
      diseases.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood glucose</measure>
    <time_frame>2 hour postprandially</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>plasma triglyceride</measure>
    <time_frame>4 hour postprandially</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>femoral artery blood flow</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>brachial artery flow-mediated dilation</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>insulin</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>glucagon</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>GIP</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>GLP</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Oral Glucose Tolerance Test</condition>
  <condition>High Fat Tolerance Test</condition>
  <arm_group>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 g of glucose in a fruit punch flavored 8 oz drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High fat tolerance test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single high fat load determined by body weight.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>non-fat milk</intervention_name>
    <description>1 serving of non-fat fluid milk</description>
    <arm_group_label>High fat tolerance test</arm_group_label>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>carbohydrate control beverage</intervention_name>
    <description>1 serving of carbohydrate control beverage (Carbohydrate powder + water)</description>
    <arm_group_label>High fat tolerance test</arm_group_label>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>caloric control beverage</intervention_name>
    <description>1 serving of caloric control beverage (carbohydrate powder + protein powder + water)</description>
    <arm_group_label>High fat tolerance test</arm_group_label>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Apparently health, sedentary. All subjects will have a BMI of 25-35 kg/m2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Candidates who are taking cardiovascular-acting drugs will not be eligible for&#xD;
             participation. Subjects with significant intima-media thickening, plaque formation,&#xD;
             characteristics of atherosclerosis, metabolic diseases, gastrointestinal disorders,&#xD;
             and/or renal disease will be excluded from the study. Additional exclusion criteria&#xD;
             will be cow milk allergy or lactose intolerance, pregnancy or lactation, and alcohol&#xD;
             abuse.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiovascular Aging Research Laboratory</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>September 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>September 2, 2016</last_update_submitted>
  <last_update_submitted_qc>September 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas at Austin</investigator_affiliation>
    <investigator_full_name>Miriam Pearman-Leary</investigator_full_name>
    <investigator_title>Doctoral Candidate</investigator_title>
  </responsible_party>
  <keyword>endothelial dependent vasodilation</keyword>
  <keyword>blood flow</keyword>
  <keyword>blood glucose</keyword>
  <keyword>triglycerides</keyword>
  <keyword>non-fat milk</keyword>
  <keyword>dairy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Hypertriglyceridemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

